CD8A and COVID-19: We found that NKG7 was downregulated in CD8+ TEMRAs, CD8+ EM, non-VD2 gamma deltas, and gamma delta T cells when compared to baseline (day -2) in COVID-19-treated subjects but not untreated controls (SI Appendix, Fig. S5A).